切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2010, Vol. 04 ›› Issue (04) : 355 -359. doi: 10.3877/cma.j.issn.1674-0793.2010.04.015

所属专题: 专题评论 文献

论著

CT灌注成像在术前评估原发性肝癌合并肝纤维化者肝储备功能中的价值初探
胡剑飞1,(), 雷正明2, 谢云川3, 付文广2   
  1. 1. 610213 双流县第二人民医院肝胆外科
    2. 泸州医学院附属医院肝胆外科
    3. 泸州医学院附属医院CT室
  • 收稿日期:2009-11-23 出版日期:2010-08-01
  • 通信作者: 胡剑飞
  • 基金资助:
    四川省卫生厅科研项目(080185)

Preliminary explore the value of CT perfusion imaging for evaluating pre-operative hepatic functional reserve of primary liver cancer complicated with hepatic fibrosis

Jian-fei HU1,(), Zheng-ming LEI2, Yun-chuan XIE3, Wen-guang FU2   

  1. 1. Department of Hepatobiliary Surgery, the Second People’s Hospital, Shuangliu 610213, China
  • Received:2009-11-23 Published:2010-08-01
  • Corresponding author: Jian-fei HU
  • About author:
    Corresponding auther: HU Jian-fei, Email:
引用本文:

胡剑飞, 雷正明, 谢云川, 付文广. CT灌注成像在术前评估原发性肝癌合并肝纤维化者肝储备功能中的价值初探[J/OL]. 中华普通外科学文献(电子版), 2010, 04(04): 355-359.

Jian-fei HU, Zheng-ming LEI, Yun-chuan XIE, Wen-guang FU. Preliminary explore the value of CT perfusion imaging for evaluating pre-operative hepatic functional reserve of primary liver cancer complicated with hepatic fibrosis[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2010, 04(04): 355-359.

目的

初步探讨CT灌注(CTP)成像术前评估原发性肝癌合并肝纤维化者肝储备功能的价值。

方法

以18例原发性肝癌合并肝纤维化患者为试验组,以10例健康者为对照组。试验组术前行肝脏CTP扫描筛检S1~S4期敏感的CTP参数;分析CTP结合Child-Pugh分级、标准残肝体积比(STELV)与患者术后出现肝功能障碍发生的关系。

结果

①术前所有患者均为Child-Pugh A级,肝实质纤维化属S1~S4期,CT扫描无明显肝硬化形态学的改变。门静脉灌注量(HPP)、肝动脉灌注量(HAP)、总肝灌注量(TLP)、门静脉灌注指数(PPI)试验组分别为(85.94±6.00)ml·min-1·100g-1、(27.89±4.74)ml·min-1·100g-1、(113.83±2.39)ml·min-1·100g-1、(0.75±0.10)%;对照组分别为(93.5±9.56)ml·min-1·100g-1、(25.10±2.85)ml·min-1·100g-1、(118.60±7.53)ml·min-1·100g-1、(0.78±0.11)%。两组比较,试验组HPP有明显下降,差异有统计学意义;TLP、HAP和PPI差异无统计学意义。②术后在Child-Pugh A级基础上,以术后肝功能障碍出现的有无作为判别结果,以HPP和STELV作为判别指标,经判别分析建立方程:f1=5.533X1+375.418X2-382.957,f2=5.221X1+354.685X2-341.385,Wilks' Lambda值为0.610,P<0.05。

结论

HPP能反映肝纤维化S1~S4期肝血流的变化,结合CTP参数和STELV,能建立有意义的判别方程,初步评估原发性肝癌合并肝纤维化者的肝储备功能。

Objective

To preliminary explore the value of CT perfusion for evaluating pre-operative hepatic functional reserve of primary liver cancer complicated with hepatic fibrosis.

Methods

The test group included 18 cases of primary liver cancer complicated with hepatic fibrosis of S1-S4. The control group included 10 cases of healthy. All patients were given preoperative heptic CT perfusion scan for screening a sensitive parameter of CTP when hepatic parenchyma had fibrosis of S1-S4. To analyse relationship of dysfunction and the parameter of CTP combinating Child-Pugh classification and STELV.

Results

Before operation, all patients in the test group were in A geade. The degree of hepatic parenchyma was all in the degree of S1-S4. Through preoperative CT scan, obvious change of cirrhosis in shape and profile was not found. The data of HPP, HAP, TLP and PPI were (85.94±6.00) ml·min-1·100g-1, (27.89±4.74) ml·min-1·100g-1, (113.83±2.39) ml·min-1·100g-1 and (0.75±0.10)%. That of the control group were (93.5±9.56) ml·min-1·100g-1, (25.10±2.85) ml·min-1·100g-1, (118.60±7.53) ml·min-1·100g-1 and (0.78±0.11)%. HPP of the test group was significant lower than the control group. TLP, HAP and PPI of the test group were not significant difference comparing with those of the control group. In the base of Child-Pugh A after operation, we put HPP and STELV as discriminant indicators and the emergence of hepatic dysfunction as discriminant result. Two discriminant equations were got: f1=5.533X1+375.418X2-382.957; f2=5.221X1+354.685X2-341.381. Wilks' Lambda value was 0.610, P<0.05.

Conclusions

HPP of CTP parameters can measure the change of blood flow in the degree of S1-S4. It can establish a sensible equations that can preliminary assess preoperative hepatic functional reserve of PLC.

表1 试验组与正常对照组的TLP、HPP、HAP(ml·min-1·100g-1
图1 以HPP和STELR为变量绘制的散点图,'1’表示术后无并发症,'2’表示术后发生并发症
1
吴在德.外科学. 6版.北京:人民卫生出版社,2004: 542-545.
2
Fazakas J, Mándli T, Ther G,et al. Evaluation of liver function for hepatic resection. Transplant Proc,2006,38(3):798-800.
3
Wakabayashi H, Ishimura K, Izuishi K,et al. Evaluation of liver function for hepatic resection for hepatocellular carcinoma in the liver-damaged parenchyma. J Surg Res,2004,116(2):248-252.
4
Herold C, Heinz R, Niedobitek G,et al. Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C. Liver,2001,21(4):260-265.
5
Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology,1993,188(2):405-411.
6
Tian JL, Zhang JS. Hepatic perfusion disorder: etipaogenesis and related disease. World J Gastroenterol,2006,12(20):3265-3270.
7
Pandharipande PV, Krinsky GA, Rusinek H,et al. Perfusion imaging of the liver: current chanllenge and future goal. Radiology,2005,234(3):661-673.
8
Guan S, Zhao WD, Zhou KR,et al. CT perfusion at early stage of hepatic diffuse disease.World J Gastroenterol,2005,11(22):3465-3467.
9
马春梅,郭启永,廖勇,等. CT灌注成像在兔肝纤维化模型的研究.中国医学影像技术,2007,23(5):641-644.
10
Yamanka N, Okamoto E, Kuwata K,et al. A multiple regressing equation for prediction of posthepatectomy liver failure. Ann Surg,1984,200(5):658-663.
11
Yamanka N, Okamoto E, Oriyama T. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg,1994,219(4):342-346.
12
袁友红,肖恩华.肝磁共振血流灌注成像及进展.中国医学影像技术,2004,20(1):159-162.
13
连海英,张雪林.磁共振灌注成像在肝硬化的临床应用.国外医学(临床放射学分册),2006,29(1):36-39.
14
Fuentes MA, Keith CJ, Griffiths M,et al. Hapatic haemodynamics: interrelationships between contrast enhancement and perfusion on CT and Doppler perfusion indices. Br J Radiol,2002,75(889):17-23.
15
Annet L, Materne R, Danse E,et al. Hepatic flow parameters measured with MR imaging and Doppler Us:correlations with degree of cirrhosis and portal hypertention. Radiology,2003,229(2):404-414.
[1] 李敏, 杨世英, 高晓琴, 周丹, 唐筱, 张立婷. 维生素A与慢性肝病相关性研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(02): 65-70.
[2] 张麒, 马臻. 丙型肝炎肝纤维化进展影响因素及标志物研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(01): 1-6.
[3] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[4] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[5] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[6] 马立伟, 贾志强, 陈午盛, 邵明亮, 刘琼, 段玉松. CalliSpheres载药微球联合碘化油治疗肝癌的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 369-372.
[7] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[8] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[9] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[10] 李刚, 潘晓帆, 田雪, 刘路路. CT灌注成像参数及血栓弹力图对急性前循环脑梗死早期神经功能恶化的预测价值分析[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 226-232.
[11] 鲍乐, 刘颖, 王友彬, 陈龙, 朱玉芝, 梁爽, 权鹤太, 李鹏飞. 还阳通络灸在原发性肝癌介入治疗中的临床应用研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 197-202.
[12] 江浩, 余宏圣, 杨碧兰, 阿布都克尤木·斯马依, 吴斌, 杨逸冬. 基于列线图模型对慢性乙型肝炎合并肝脏脂肪变性患者并发晚期肝纤维化的临床预测[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 114-120.
[13] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[14] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
[15] 肖西洋, 金光, 孙润杰, 崔鹤松. IL-10基因位点rs1554286(G/A)多态性与延边地区原发性肝癌的预后分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(11): 1169-1175.
阅读次数
全文


摘要